(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.32%) $79.20
(-0.05%) $2.03
(0.16%) $2 313.30
(0.30%) $26.91
(0.04%) $963.00
(-0.02%) $0.932
(-0.04%) $10.99
(-0.05%) $0.797
(-0.01%) $91.12
Live Chart Being Loaded With Signals
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases...
Stats | |
---|---|
Today's Volume | 52 106.00 |
Average Volume | 78 626.00 |
Market Cap | 244.22M |
EPS | $-0.420 ( 2024-03-13 ) |
Next earnings date | ( $0 ) 2024-05-08 |
Last Dividend | $2.50 ( 2021-07-15 ) |
Next Dividend | $0 ( N/A ) |
P/E | -9.90 |
ATR14 | $0.0480 (0.59%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-03 | Simard John | Buy | 2 470 355 | Convertible Loan Agreement |
2023-06-23 | Waldin Jan-paul | Buy | 25 000 | Director Stock Option |
2023-06-23 | Libby Peter | Buy | 25 000 | Director Stock Option |
2023-06-23 | Macadam Donald H. | Buy | 25 000 | Director Stock Option |
2023-06-23 | Mckenzie W Thorpe | Buy | 25 000 | Director Stock Option |
INSIDER POWER |
---|
97.98 |
Last 100 transactions |
Buy: 4 116 188 | Sell: 11 979 897 |
Volume Correlation
XBiotech Inc Correlation
10 Most Positive Correlations | |
---|---|
VVOS | 0.88 |
BPRN | 0.871 |
BELFA | 0.856 |
CGO | 0.845 |
CNTY | 0.845 |
PASG | 0.84 |
APLD | 0.838 |
DORM | 0.831 |
BBCP | 0.815 |
ATNX | 0.812 |
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
XBiotech Inc Correlation - Currency/Commodity
XBiotech Inc Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-1.74M (0.00 %) |
EPS: | $-0.810 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-1.74M (0.00 %) |
EPS: | $-0.810 |
FY | 2022 |
Revenue: | $4.01M |
Gross Profit: | $3.36M (83.77 %) |
EPS: | $-1.080 |
FY | 2021 |
Revenue: | $18.39M |
Gross Profit: | $12.57M (68.36 %) |
EPS: | $-0.580 |
Financial Reports:
No articles found.
XBiotech Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $2.50 | 2021-07-15 |
Last Dividend | $2.50 | 2021-07-15 |
Next Dividend | $0 | N/A |
Payout Date | 2021-07-23 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $2.50 | -- |
Avg. Dividend % Per Year | 1.55% | -- |
Score | 0.63 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2021 | $2.50 | 15.50% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -9.37 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.108 | 1.200 | -3.60 | -4.32 | [0 - 0.3] |
returnOnEquityTTM | -0.108 | 1.500 | -2.31 | -3.47 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 33.07 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 32.94 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 32.79 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.615 | 2.00 | -0.205 | -0.410 | [0 - 30] |
freeCashFlowPerShareTTM | -0.627 | 2.00 | -0.314 | -0.627 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.334 | 1.000 | 7.76 | 7.76 | [0.2 - 0.8] |
operatingProfitMarginTTM | -14.32 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0.0115 | 0.800 | -3.26 | -2.61 | [0.5 - 2] |
Total Score | -0.390 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -10.11 | 1.000 | -1.123 | 0 | [1 - 100] |
returnOnEquityTTM | -0.108 | 2.50 | -1.487 | -3.47 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.627 | 2.00 | -0.209 | -0.627 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.615 | 2.00 | -0.205 | -0.410 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.0847 | 1.500 | -2.77 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -7.15 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -1.982 |
XBiotech Inc
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators